Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
about
Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasisPathogen- and host-directed anti-inflammatory activities of macrolide antibioticsMacrolide antibiotics and bronchiolitis obliterans following lung transplantation.Interfering with extracellular matrix degradation to blunt inflammationAttacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?Novel effects of macrolide antibiotics on cardiovascular diseases.Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler.Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury.Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.Role of AP-1 family proteins in regulation of inducible nitric oxide synthase (iNOS) in human neutrophils.Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro.Macrolides for macrophages in chronic obstructive pulmonary disease.
P2860
Q33463373-B882F3C0-1B32-4C19-9C0F-C6FE0841F84EQ34530078-72A6FF1A-A50D-4BFE-81A1-F511F1780704Q36072425-19C5B617-52FD-4B00-A856-D226ACF54B0BQ36322121-E86918DB-4C48-4DB0-A6F3-EFFF793D5373Q37112292-D54FFD93-3FB3-4FE0-91D3-1E9C1A1618DAQ37332258-88E52367-9E47-4198-8BC5-2DFA68B89DE8Q37691452-98EE85B1-999C-4A6F-BFB2-00734A0FC4CAQ37964006-AFE5D223-A4A4-4D33-89DA-6EF13D01D0E0Q38925706-B42CEFFB-70BF-4E67-BE36-FC6339049239Q41175836-740D38E9-92BF-4B07-B01C-7BB50282A710Q43549706-30094BF4-E3DA-4F43-8036-FBE11B23BC04Q45955013-630D28C5-F7F0-4C23-9C54-BF88A2B19AF8Q46540016-E90996E6-C724-42AF-B35A-9E002EFE816BQ46879755-DD050A70-0ECE-4496-B7B4-CDB74AA1C79AQ54337018-6D2F4707-B94C-4638-AED0-5C96544E13FD
P2860
Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Suppression of matrix metallop ...... iotic, roxithromycin, in vitro
@en
type
label
Suppression of matrix metallop ...... iotic, roxithromycin, in vitro
@en
prefLabel
Suppression of matrix metallop ...... iotic, roxithromycin, in vitro
@en
P2093
P2860
P1476
Suppression of matrix metallop ...... iotic, roxithromycin, in vitro
@en
P2093
Harumi Suzaki
Kazuhito Asano
Ken-Ichi Kanai
Tadashi Hisamitsu
P2860
P304
P356
10.1080/09629350400008810
P577
2004-12-01T00:00:00Z